Abbott Wants To Expand Clinical Trial Access By Diversifying Investigator Community
The company’s plan to reduce barriers to clinical trial participation for underrepresented groups includes the creation of nearly 300 new scholarships at medical schools of historically black colleges and universities and minority nursing associations.
You may also be interested in...
The company announced new research investments and partnerships with the American Diabetes Association and the T1D Exchange to address racial disparities in treatment of diabetes.
Abbott will commit $5m to support the ADA’s efforts to bring diabetes technologies and education to underserved diabetes populations.
The Esprit BTK everolimus-eluting resorbable scaffold is designed to treat arteries below the knee. No stents or drug-coated balloons are currently FDA-approved for that indication.